Kiwi Biosciences (FODZYME) Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Kiwi Biosciences, based in Cambridge, Massachusetts, operates in the biotechnology research space with a focus on enzyme-based solutions for digestive health. The company targets the roughly 40 million Americans who suffer from Irritable Bowel Syndrome and related gut disorders by addressing dietary triggers that commonly provoke symptoms. Its first patent-pending product, FODZYME, is designed to break down triggers found in foods such as garlic, onion, wheat, and banana, enabling people to eat a broader range of foods without discomfort. 
Kiwi Biosciences operates as a small team within the biotechnology sector, aiming to translate enzyme science into practical dietary tools for individuals managing gut-related symptoms. In early 2023, the company was recognized as a finalist in two competitions, including Harvard iLabs' President's Innovation Challenge and the Alumni & Affiliates Open track.

Sign up for free to view info

Company overview Email format